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an important innate immune mechanism for combating 
intracellular pathogens [3]. The existence of this unusual 
cell death modality was first implied in 1992, when the 
Sansonetti laboratory observed that murine macrophages 
infected with the Gram-negative bacterium, Shigella 
flexneri, undergo a form of cell death similar to apoptosis 
[4]. The Falkow laboratory made similar observations in 
cells infected with a closely related pathogen, Salmonella 
Typhimurium, reporting the presence of DNA degradation, 
changes in nuclear morphology and vacuole formation 
[5]. In addition to these apoptosis-like features, Cookson 
and co-workers reported that cell death by such infected 
cells also presented features similar to necrosis [6]. These 
cells formed membrane pores of 1-2.5 nm and displayed 
swelling and Ca2+ influx, leading to membrane rupture 
and the extracellular release of cellular contents. This 
unusual form of pathogen-induced cell death, containing 
hallmarks of both apoptosis and necrosis [6], was found 
to be dependent on the activity of a proinflammatory 
protease, caspase-1 [5]. The term ‘pyroptosis’ was coined 
by Cookson and Brennan in 2001 to distinguish this form 
of cell death from apoptosis and necrosis [7]. 
2  Pyroptosis initiation by canonical 
Caspase-1 inflammasomes
Caspase-1 is a protease that drives potent inflammatory 
responses. Caspase-1 consists of a N-terminal CARD 
domain, followed by a bipartite catalytic domain, 
composed of large and small subunits [8]. The protease 
is synthesized within the cell as an inactive monomeric 
zymogen (pro-caspase-1) and is activated upon formation 
of the inflammasome, a large molecular signalling complex 
that assembles upon sensing of microbial or endogenous-
derived danger molecules [9-12]. So-called canonical 
inflammasomes are composed of a sensor molecule and 
caspase-1, and often include the common adaptor protein, 
ASC. Sensing of endogenous or pathogen-derived danger 
molecules occurs through one or more nucleotide-binding 
domain and leucine-rich repeat containing receptor (NLR) 
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1  Introduction
Regulated cell death was first described in 1964 by 
Lockshin and William and is an essential process to 
maintain homeostasis in living organisms [1]. Decades 
of subsequent research uncovered multiple specialised 
forms of cell death such as apoptosis, necroptosis, NETosis 
and pyroptosis [2]. Pyroptosis has recently emerged as 
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(e.g. NLRP1, NLRP3, or a collaboration between NLRC4 and 
NAIP) or HIN-200 (e.g. AIM2) receptor family members. 
Detection of such signals drives the oligomerisation of 
the sensor protein into a multimeric hub that enables 
downstream recruitment and clustering of ASC. ASC 
acts as a signal adaptor that, upon binding to the sensor 
protein, recruits pro-caspase-1 to the complex. Pro-
caspase-1 clustering within the inflammasome complex 
enables its activation through homodimerisation, an 
essential and probably sufficient step for the acquisition 
of enzymatic activity, which may be further influenced by 
self-cleavage [8, 13, 14]. Self-processing occurs between 
the large and the small subunit of caspase-1, and appears 
to be mandatory for caspase-1-directed maturation of 
the inflammasome target cytokines, IL-1β and IL-18. This 
cleavage event may be associated with stabilisation of 
the active site, as reported for initiator apoptotic caspases 
[15]. In contrast, self-processing between the large and the 
small subunits appeared dispensable for the initiation 
of pyroptosis, as wild-type and uncleavable mutants of 
caspase-1 were equally able to trigger pyroptosis in murine 
macrophages [14]. Pyroptosis execution does however 
absolutely require the catalytic activity of caspase-1 [5, 14]. 
Caspase-1 is also cleaved in the linker between the CARD 
domain and the catalytic domain, but the outcome of 
this cleavage event remains unclear. While the molecular 
events directing pyroptosis execution downstream of 
caspase-1 activation are currently unknown, it is widely 
believed that this process involves proteolytic activation 
of specific pyroptotic death effector molecules, akin to 
the pathways controlling apoptosis. We recently reported 
that caspase-1 activation in neutrophils selectively triggers 
cytokine processing without concomitant cell death, 
suggesting that individual cell types may suppress the 
availability of pyroptotic death effectors as a means to 
modulate cell viability at a site of challenge [16]. 
3  Pyroptosis initiation by other 
inflammatory caspases
Emerging studies now suggest that other inflammatory 
caspases are also recruited to, and activated by, 
inflammasomes. The inflammatory caspase sub-family 
is comprised of caspases-1, -4, -5, and -12 in humans and 
-1, -11, and -12 in mice. Caspase-11 has gained considerable 
attention in recent years, as it is activated upon intracellular 
delivery of bacterial lipopolysaccharide (LPS), and is 
implicated into endotoxemia [17, 18]. Like caspase-1, active 
caspase-11 triggers pyroptosis. Surprisingly, caspase-11 
appears unable to directly cleave cytokines, and only does 
so indirectly through an unresolved mechanism involving 
NLRP3 and caspase-1 [19]. Recent studies suggest that 
caspase-11 is activated through a surprising mechanism 
involving direct interaction between the pro-caspase-11 
CARD domain and LPS, triggering caspase dimerisation 
and activation, within the so-called ‘non-canonical 
inflammasome’ complex [20]. This finding for caspase-
11 is the first to suggest that inflammatory caspase may 
perform dual functions, encompassing both ligand sensor 
and effector activities, within an inflammasome complex. 
Caspase-4 and -5 are the human orthologs of murine 
caspase-11, and are currently not well characterised. 
These caspases also shared the LPS-binding properties 
of caspase-11 [20], implying activation through a similar 
mechanism. The limited literature on these human 
caspases suggests their activation by intracellular 
pathogens, and proposes functions in triggering IL-18 
production and pyroptosis in infected epithelial cells 
[21]. Studies from a transgenic mouse expressing human 
caspase-4 implicated this caspase, like murine caspase-
11, as an important mediator of endotoxin sensitivity [22]. 
The evolution of multiple inflammatory caspases capable 
of pyroptosis initiation highlights the importance of this 
process as an anti-microbial defence strategy.
4   Pyroptosis as a pathogen 
clearance mechanism
Several important human pathogens establish an 
intracellular niche within host cells, where they can 
proliferate and protect themselves from soluble immune 
mediators. Gram-negative Salmonella spp, which cause 
typhoid fever and gastroenteritis, is one such example 
of an intracellular bacterium. Several studies have 
demonstrated clear functions for inflammasomes in 
controlling the replication of Salmonella, through cytokine 
activation and induction of pyroptosis [16, 23, 24]. 
Pyroptosis of infected cells is emerging as an important 
mechanism of microbial clearance [24], in addition to host 
defence mechanisms coordinated by inflammasome-
dependent IL-1β [16], and IL-18 [23, 25]. Macrophage 
pyroptosis releases Salmonella from its intracellular 
replicative niche, and increases its susceptibility to 
neutrophil-mediated extracellular destruction (Figure  1). 
This mechanism also appears effective in limiting the 
replication of other intracellular pathogens, including 
Legionella and Burkholderia [24]. In addition to removing 
the bacterial replicative niche, pyroptosis also passively 
releases multiple alarmins [26, 27] such as ATP, IL-33 [28] 
and HMGB1 [29] to alert and recruit immune cells to the site 
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of infection [30]. The oligomeric form of the adaptor protein 
ASC can also act as an unusual alarmin released during 
pyroptosis that can propagate inflammasome signalling 
in surrounding macrophages [31, 32]. Pyroptotic cells are 
reported to undergo lysosomal exocytosis [33] to release 
lysosomal antimicrobial peptides [34] that facilitate the 
clearance of pathogens by recruiting neutrophils.
The ability to undergo pyroptotic death is not unique 
to immune cells. For example, pyroptosis of the gut 
epithelium promotes the extrusion of infected cells into 
the gut lumen, preventing Salmonella, and probably other 
pathogens, from transversing the epithelial barrier to 
invade the host [21, 35]. 
5  Pyroptosis inhibition or evasion 
by pathogens
Constant host-pathogen interactions have provided 
selection pressure for pathogens to evolve and subvert host 
antimicrobial mechanisms. It is therefore not surprising 
that many pathogens have devised strategies to block 
pyroptosis. Most of the reported subversion strategies 
target inflammasome function or caspase activity, and 
so target both cytokine processing and pyroptotic death. 
For example, intracellular Salmonella evades recognition 
by the NAIP-NLRC4 inflammasome by repressing the 
expression of bacterial ligands detected by this pathway 
(e.g. bacterial flagellin and the Salmonella pathogenicity 
island-1 type 3 secretion system) [24]. Yersinia species 
limit the enzymatic activity of caspase-1 by secreting a 
pseudosubstrate inhibitor, YopM, to prevent pyroptosis 
and limit cytokine production [36]. Shigella actively 
prevents caspase-4-dependent cell death by secreting 
OspC3, a direct and specific inhibitor of caspase-4 [37]. 
These examples illustrate the diverse strategies bacteria 
employ to bypass host defence mechanisms. Viruses 
have also evolved strategies to subvert pyroptosis and 
cell death more generally [38]. These strategies include 
the generation of decoy molecules to limit inflammasome 
alarmins
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Figure 1: Macrophage and neutrophils together coordinate pathogen control, via macrophage pyroptosis and continued neutrophil viabi-
lity. In macrophages, pathogen recognition by a cytosolic inflammasome sensor triggers inflammasome assembly, caspase-1 activation, 
cytokine maturation and pyroptotic death. Pyroptosis is presumably executed via proteolytic activation of an unknown pyroptotic effector 
protein, and serves to release intracellular microbes such as Salmonella Typhimurium to the extracellular space. Caspase-1-dependent 
release of cytokines (e.g. IL-1β) and alarmins (e.g. IL-1α) triggers neutrophil recruitment to the site of infection, where they sense pathogens 
and trigger inflammasome assembly. Inflammasome activation in neutrophils triggers caspase-1-dependent IL-1β production in a positive 
amplification loop to ensure neutrophil influx and activation. The inability of neutrophils to undergo pyroptotic death, presumably due to 
pyroptotic effector unavailability, allows IL-1β secretion to be sustained, and enables neutrophils to execute their potent anti-microbial 
functions to clear the infection.
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activation and the production of protease inhibitors to 
prevent inflammatory caspase activity, and are discussed 
in greater detail elsewhere [39]. 
Immune cells can also die through other programmed 
cell death pathways such as apoptosis and necroptosis, 
which are often initiated in parallel to pyroptosis, possibly 
as a means to thwart microbial subversion of pyroptotic 
pathways. One clear example of a cellular backup plan to 
control pathogen proliferation following inflammasome 
activation is the concurrent activation of caspase-8 
alongside caspase-1 within the ASC speck, leading to the 
execution of apoptosis if pyroptosis is blocked [40, 41]. 
6  The dark side of pyroptosis in 
pathogen clearance
While pyroptosis is an important innate immune 
mechanism to clear intracellular pathogens, under 
some situations, pyroptotic death can also facilitate 
pathogenicity and drive immune pathologies. An excellent 
example is the case of human immunodeficiency virus 
(HIV) infection. Depletion of CD4 T cells is a hallmark 
of HIV pathophysiology, and is the main driver of 
acquired immunodeficiency syndrome (AIDS) [42]. Two 
recent studies unravelled mechanisms of CD4 T cell 
depletion during HIV infection [43, 44]. The authors 
demonstrated that abortive HIV infection in quiescent 
CD4 T cells triggered caspase-1-mediated pyroptosis. In 
this scenario, pyroptosis of quiescent CD4 T cells does 
not necessarily deprive HIV of its replicative niche, as 
this cell population is not permissive for viral replication. 
HIV instead replicates in activated CD4 T cells, which 
represent only a minority of the CD4 T cell population, 
and die by apoptosis. Pyroptosis in quiescent CD4 T 
cells promoted chronic CD4 T cell depletion, driving the 
progression of AIDS [43-45]. Another example in which 
pyroptosis may be detrimental is that of NLRP1a-mediated 
pyroptosis in haematopoietic progenitor cells during 
haematopoietic stress induced by chemotherapy or bone 
marrow infection [46]. Although seemingly intended as 
a mechanism to prevent infection of daughter cells from 
compromised haematopoietic progenitor cells, chronic 
pyroptosis resulted in cytopenia and immunosuppression 
[46, 47]. Lastly, caspase-11-mediated pyroptosis may 
drive lethal endotoxemia by mediating the release 
of intracellular inflammatory mediators [17, 18, 48]. 
Collectively, such observations highlight the potential for 
pyroptosis to mediate pathology under certain conditions. 
Nonetheless, more research is required to assess the 
balance of beneficial versus detrimental effects of 
pyroptosis in different settings. Identification of specific 
pyroptotic effector(s) will be instrumental for such further 
investigation, as current genetic approaches do not allow 
the outcomes of pyroptosis to be evaluated in isolation 
from other inflammasome-dependent functions in murine 
models of disease.
7  Concluding remarks
While the current literature documents the tremendous 
importance of pyroptosis in mediating control of intracellular 
pathogens, many questions remain unanswered. One such 
question is the precise function of pyroptosis when cell 
death is initiated by a non-microbial (sterile) signal, such 
as extracellular ATP. In addition, the molecular events that 
initiate and regulate pyroptosis upon caspase activation 
are unknown and remain an exciting field of investigation. 
Further research is required to establish the requirement for 
individual candidate caspase-1 substrates in the execution of 
pyroptosis, as such knowledge may allow the development 
of targeted therapies for pyroptosis-driven pathologies. The 
future development of drugs that selectively target individual 
inflammatory caspases will also yield great insight into 
pyroptosis mechanisms and function, and have potential for 
the treatment of human diseases. This potential is illustrated 
in the suggested usage of a caspase-1 inhibitor to limit CD4 T 
cell depletion during HIV infection. However, many pitfalls 
plague pyroptosis research. The absence of a genetic mouse 
model that specifically blocks pyroptosis considerably limits 
our ability to delineate pyroptosis functions in vivo. Moreover, 
discrepancies between the immune systems of humans and 
mice [49], for example the low evolutionary similarity within 
inflammatory caspases [12], limit our full understanding of 
pyroptosis in human health and disease. This highlights 
the necessity for future research examining pyroptosis 
mechanisms and functions in a context clearly relevant for 
humans and the pathogens to which we are exposed. 
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